Formulation: A solid
Formal Name: 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-(cyclopropyl-1,2,2,3,3-d5)-2-(2-fluorophenyl)-ethanone
Purity: ≥99% deuterated forms (d1-d5)
Formula Markup: C20H15D5FNO3S
Formula Weight: 378,5
Shelf life (days): 1460
CAS Number: 1127252-92-9
Notes: Prasugrel-d5 is intended for use as an internal standard for the quantification of prasugrel (Item No. 14278) by GC- or LC-MS. Prasugrel is a prodrug form of the platelet purinergic P2Y12 receptor antagonist R-99224.{23698} Prasugrel (0.3 and 3 mg/kg) inhibits ex vivo washed platelet aggregation in rat platelet rich-plasma.{23697} In vivo, prasugrel prevents thrombus formation (ED50 = 0.68 mg/kg) and increases tail bleeding time in rats. Formulations containing prasugrel have been used in the prevention of blood clots.